Invesco’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.36M | Sell |
68,924
-192,978
| -74% | -$12.2M | ﹤0.01% | 2260 |
|
2025
Q1 | $13.9M | Sell |
261,902
-40,944
| -14% | -$2.17M | ﹤0.01% | 1607 |
|
2024
Q4 | $17M | Buy |
302,846
+38,429
| +15% | +$2.15M | ﹤0.01% | 1575 |
|
2024
Q3 | $13.9M | Sell |
264,417
-12,283
| -4% | -$644K | ﹤0.01% | 1663 |
|
2024
Q2 | $11.4M | Buy |
276,700
+188,495
| +214% | +$7.74M | ﹤0.01% | 1725 |
|
2024
Q1 | $3.82M | Sell |
88,205
-47,526
| -35% | -$2.06M | ﹤0.01% | 2381 |
|
2023
Q4 | $6.24M | Buy |
135,731
+107,357
| +378% | +$4.94M | ﹤0.01% | 2124 |
|
2023
Q3 | $650K | Buy |
28,374
+98
| +0.3% | +$2.25K | ﹤0.01% | 3060 |
|
2023
Q2 | $466K | Buy |
+28,276
| New | +$466K | ﹤0.01% | 3265 |
|
2023
Q1 | – | Sell |
-334,273
| Closed | -$9.73M | – | 3970 |
|
2022
Q4 | $9.73M | Buy |
+334,273
| New | +$9.73M | ﹤0.01% | 1862 |
|
2022
Q2 | – | Sell |
-16,507
| Closed | -$190K | – | 4090 |
|
2022
Q1 | $190K | Sell |
16,507
-7,741
| -32% | -$89.1K | ﹤0.01% | 3742 |
|
2021
Q4 | $243K | Sell |
24,248
-3,085
| -11% | -$30.9K | ﹤0.01% | 3670 |
|
2021
Q3 | $357K | Buy |
27,333
+2,025
| +8% | +$26.4K | ﹤0.01% | 3552 |
|
2021
Q2 | $495K | Buy |
25,308
+8,101
| +47% | +$158K | ﹤0.01% | 3402 |
|
2021
Q1 | $366K | Buy |
17,207
+2,595
| +18% | +$55.2K | ﹤0.01% | 3447 |
|
2020
Q4 | $434K | Buy |
14,612
+4,648
| +47% | +$138K | ﹤0.01% | 3250 |
|
2020
Q3 | $216K | Sell |
9,964
-170
| -2% | -$3.69K | ﹤0.01% | 3405 |
|
2020
Q2 | $226K | Sell |
10,134
-993
| -9% | -$22.1K | ﹤0.01% | 3400 |
|
2020
Q1 | $169K | Buy |
+11,127
| New | +$169K | ﹤0.01% | 3418 |
|